Trial Profile
Planned phase II or II/III trials of intralesional rose bengal sodium [PV 10] for the treatment of liver cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2013
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Provectus Biopharmaceuticals
- 20 May 2013 This trial is still in the planning stage.
- 17 Sep 2010 New trial record